X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3189) 3189
Publication (355) 355
Book Review (10) 10
Book Chapter (5) 5
Conference Proceeding (3) 3
Dissertation (2) 2
Book / eBook (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1841) 1841
index medicus (1311) 1311
humans (1194) 1194
male (1166) 1166
rats (965) 965
pharmacology & pharmacy (901) 901
palmitates - pharmacology (873) 873
female (620) 620
mice (611) 611
palmitate (584) 584
palmitates - metabolism (570) 570
biochemistry & molecular biology (476) 476
paliperidone palmitate (432) 432
adult (373) 373
fatty acids (373) 373
cells, cultured (339) 339
schizophrenia (339) 339
cell line (312) 312
endocrinology & metabolism (309) 309
metabolism (303) 303
cell biology (295) 295
apoptosis (287) 287
middle aged (278) 278
risperidone (269) 269
psychiatry (267) 267
dose-response relationship, drug (266) 266
glucose (261) 261
glucose - metabolism (253) 253
fatty acids - metabolism (249) 249
oxidation-reduction (241) 241
physiology (238) 238
schizophrenia - drug therapy (237) 237
insulin resistance (236) 236
in vitro techniques (235) 235
insulin - metabolism (226) 226
liver - metabolism (221) 221
rats, sprague-dawley (220) 220
insulin (218) 218
apoptosis - drug effects (212) 212
time factors (212) 212
activation (199) 199
research (198) 198
antipsychotic agents - administration & dosage (196) 196
analysis (188) 188
oxidative stress (186) 186
antipsychotic agents - therapeutic use (181) 181
physiological aspects (179) 179
expression (178) 178
signal transduction - drug effects (178) 178
palmitic acid (175) 175
rats, wistar (174) 174
obesity (173) 173
antipsychotic agents - adverse effects (169) 169
lipids (163) 163
insulin-resistance (161) 161
glucose - pharmacology (160) 160
neurosciences (158) 158
kinetics (154) 154
myocardium - metabolism (153) 153
inflammation (150) 150
insulin - pharmacology (150) 150
phosphorylation (149) 149
proteins (148) 148
inhibition (147) 147
pharmacokinetics (147) 147
research article (145) 145
endoplasmic-reticulum stress (142) 142
liver (141) 141
cell survival - drug effects (139) 139
mice, inbred c57bl (139) 139
cells (135) 135
fatty acids - pharmacology (134) 134
lipid metabolism (134) 134
palmitates - chemistry (130) 130
palmitic acid - pharmacology (130) 130
antipsychotic agents - pharmacokinetics (129) 129
cell line, tumor (129) 129
insulin-secreting cells - drug effects (129) 129
palmitates (128) 128
double-blind (126) 126
insulin secretion (125) 125
liver - drug effects (123) 123
toxicology (123) 123
diabetes (122) 122
enzyme inhibitors - pharmacology (122) 122
fatty-acids (119) 119
skeletal-muscle (118) 118
triglycerides - metabolism (118) 118
signal transduction (117) 117
article (116) 116
biophysics (116) 116
reactive oxygen species - metabolism (115) 115
insulin-secreting cells - metabolism (114) 114
gene expression (113) 113
muscle, skeletal - metabolism (113) 113
efficacy (110) 110
rodents (110) 110
young adult (109) 109
aged (105) 105
safety (105) 105
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3130) 3130
Japanese (23) 23
Chinese (10) 10
French (6) 6
Russian (6) 6
Czech (5) 5
German (4) 4
Spanish (2) 2
Danish (1) 1
Hungarian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrinology, ISSN 0013-7227, 02/2016, Volume 157, Issue 2, pp. 692 - 704
To determine the comprehensive G protein-coupled receptor (GPCR) expression profile in ghrelin-producing cells and to elucidate the role of GPCR-mediated... 
IN-VITRO | PLASMA | ACID | NOREPINEPHRINE | CIRCULATING GHRELIN | RAT STOMACH | SOMATOSTATIN | INSULIN-SECRETION | ENDOCRINOLOGY & METABOLISM | HUMANS | MICE | Immunohistochemistry | Oxytocin - pharmacology | Receptors, G-Protein-Coupled - metabolism | Receptors, Oxytocin - genetics | Muscarinic Agonists - pharmacology | Gene Expression Profiling | Gastric Mucosa - metabolism | RNA, Messenger - metabolism | Somatostatin - pharmacology | Receptors, Somatostatin - genetics | Receptors, Oxytocin - drug effects | Palmitates - pharmacology | Gastric Mucosa - drug effects | Receptors, Adrenergic, beta-1 - drug effects | Receptors, Somatostatin - metabolism | Lactic Acid - pharmacology | Receptors, G-Protein-Coupled - drug effects | Oxytocics - pharmacology | Receptors, Prostaglandin E, EP4 Subtype - agonists | Dinoprostone - pharmacology | Hormones - pharmacology | Colforsin - pharmacology | Ghrelin - drug effects | Adrenergic beta-Agonists - pharmacology | Mice, Transgenic | Receptors, Adrenergic, beta-1 - metabolism | Gastric Mucosa - cytology | Receptor, Muscarinic M4 - agonists | Ghrelin - secretion | Receptors, Oxytocin - metabolism | Animals | Sequence Analysis, RNA | Gastric Mucosa - secretion | Isoproterenol - pharmacology | Receptors, Somatostatin - drug effects | Cell Line, Tumor | Muscarine - pharmacology | Receptors, Adrenergic, beta-1 - genetics | Mice | Receptors, G-Protein-Coupled - genetics | Tryptophan - pharmacology
Journal Article
Psychopharmacology, ISSN 0033-3158, 9/2006, Volume 187, Issue 4, pp. 415 - 423
Journal Article
Psychopharmacology, ISSN 0033-3158, 9/2007, Volume 194, Issue 1, pp. 63 - 72
Paliperidone (9-OH-risperidone) is the main metabolite of the atypical antipsychotic risperidone. While both drugs are potent dopamine (D)2 antagonists, they... 
Biomedicine | Escitalopram | Dorsal raphe nucleus | Atypical antipsychotic drugs | Selective serotonin reuptake inhibitors (SSRIs) | Locus coerulus | Pharmacology/Toxicology | Psychiatry | 9-OH-Risperidone | PSYCHIATRY | ARIPIPRAZOLE AUGMENTATION | FRONTAL-CORTEX | REUPTAKE INHIBITORS | ANTAGONISM | NEUROSCIENCES | dorsal raphe nucleus | IN-VITRO | atypical antipsychotic drugs | 9-OH-risperidone | locus coerulus | selective serotonin reuptake inhibitors (SSRIs) | ANTIPSYCHOTIC-DRUGS | escitalopram | PHARMACOLOGY & PHARMACY | MAJOR DEPRESSIVE DISORDER | RECEPTOR-BINDING | BRAIN | Serotonin Antagonists - administration & dosage | Citalopram - pharmacology | Injections, Intravenous | Electrophysiology | Male | Dose-Response Relationship, Drug | Desipramine - pharmacology | Neurons - physiology | Neurons - metabolism | Norepinephrine - secretion | Neurons - drug effects | Infusion Pumps | Pyrimidines - administration & dosage | Risperidone - administration & dosage | Paliperidone Palmitate | Risperidone - pharmacology | Rats | Pyrimidines - pharmacology | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Isoxazoles - administration & dosage | Antipsychotic Agents - administration & dosage | Isoxazoles - pharmacology | Animals | Citalopram - administration & dosage | Adrenergic Uptake Inhibitors - pharmacology | Serotonin - secretion | Pyridines - pharmacology | Antipsychotic Agents - pharmacology | Serotonin 5-HT1 Receptor Antagonists | Prescription drugs | Neurology | Neurotransmitters | Psychology | Rodents | Comparative studies | Pharmacology | Biophysics
Journal Article
Bone, ISSN 8756-3282, 2008, Volume 43, Issue 2, pp. 394 - 404
Journal Article
Journal of Agricultural and Food Chemistry, ISSN 0021-8561, 05/2006, Volume 54, Issue 11, pp. 3779 - 3785
Journal Article
Journal Article
Journal Article
Forensic Science International, ISSN 0379-0738, 2013, Volume 229, Issue 1, pp. 151 - 156
Abstract Long-term stability data of atypical antipsychotics in different matrices are not widely available. The aim of this work was to assess the stability... 
Pathology | Haemolysed whole blood | Instability | Oral fluid | Atypical antipsychotics | Olanzapine | TDM | Haemolysed whole bloods | CLOZAPINE | ASSAY | MEDICINE, LEGAL | QUETIAPINE | PERFORMANCE-LIQUID-CHROMATOGRAPHY | PSYCHOTROPIC-DRUGS | TANDEM MASS-SPECTROMETRY | MATRICES | NORCLOZAPINE CONCENTRATIONS | Benzodiazepines - analysis | Sulpiride - pharmacology | Humans | Male | Quinolones - pharmacology | Saliva - chemistry | Aripiprazole | Sulpiride - analogs & derivatives | Tandem Mass Spectrometry | Clozapine - pharmacology | Dibenzothiazepines - analysis | Cattle | Quinolones - analysis | Chromatography, Liquid | Female | Forensic Toxicology - methods | Isoxazoles - analysis | Clozapine - analysis | Hemolysis | Pyrimidines - analysis | Reproducibility of Results | Sulpiride - analysis | Benzodiazepines - pharmacology | Dibenzothiazepines - pharmacology | Drug Stability | Quetiapine Fumarate | Paliperidone Palmitate | Risperidone - pharmacology | Clozapine - analogs & derivatives | Pyrimidines - pharmacology | Piperazines - pharmacology | Isoxazoles - pharmacology | Risperidone - analysis | Animals | Piperazines - analysis | Antipsychotic Agents - analysis | Antipsychotic Agents - pharmacology | Serum - chemistry | Usage | Antipsychotic drugs | Analysis | Serum | Liquid chromatography | Mass spectrometry | Blood plasma | Psychotropic drugs | Analytical chemistry | Plasma | Chromatography | Index Medicus | Human | Fluids | Stability | Fluid dynamics | Ambient temperature | Fluid flow | Serums | Blood
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 04/2011, Volume 300, Issue 4, pp. H1361 - H1372
Journal Article
Diabetologia, ISSN 0012-186X, 6/2013, Volume 56, Issue 6, pp. 1372 - 1382
Journal Article
Schizophrenia Research, ISSN 0920-9964, 07/2018, Volume 197, pp. 261 - 268
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 10/2014, Volume 31, Issue 10, pp. 2605 - 2617
Objectives Dopamine D-2 receptor occupancy (D2RO) is the major determinant of efficacy and safety in schizophrenia drug therapy. Excessive D2RO (>80%) is known... 
Biochemistry, general | Biomedical Engineering | dopamine D 2 receptor antagonist | catalepsy | Biomedicine | Pharmacy | Medical Law | EPS | Markov model | schizophrenia | Pharmacology/Toxicology | CLOZAPINE | RESPONSES | MECHANISM | ANTIPSYCHOTIC-DRUGS | PHARMACOLOGY & PHARMACY | dopamine D-2 receptor antagonist | CHEMISTRY, MULTIDISCIPLINARY | PET | Catalepsy - etiology | Markov Chains | Antipsychotic Agents - adverse effects | Humans | Risperidone - pharmacokinetics | Catalepsy - metabolism | Receptors, Dopamine D2 - metabolism | Brain - metabolism | Dose-Response Relationship, Drug | Computer Simulation | Risperidone - adverse effects | Isoxazoles - pharmacokinetics | Severity of Illness Index | Benzodiazepines - pharmacology | Paliperidone Palmitate | Risperidone - pharmacology | Rats | Dopamine D2 Receptor Antagonists - pharmacokinetics | Benzodiazepines - pharmacokinetics | Antipsychotic Agents - pharmacokinetics | Pyrimidines - pharmacology | Isoxazoles - pharmacology | Animals | Models, Biological | Pyrimidines - adverse effects | Dopamine D2 Receptor Antagonists - pharmacology | Pyrimidines - pharmacokinetics | Benzodiazepines - adverse effects | Antipsychotic Agents - pharmacology | Dopamine D2 Receptor Antagonists - adverse effects | Isoxazoles - adverse effects | Schizophrenia | Markov processes | Phenols | Dopamine | Antipsychotic drugs | Side effects | Pharmacology | Drug therapy | Rodents
Journal Article